论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Peng L, Huang YT, Chen J, Zhuang YX, Zhang F, Chen JY, Zhou L, Zhang DH
Received 6 August 2018
Accepted for publication 6 October 2018
Published 8 November 2018 Volume 2018:10 Pages 5471—5477
DOI https://doi.org/10.2147/CMAR.S182798
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Dr Ahmet Emre Eskazan
Background: Radiotherapy is one of the most comment and useful treatment for
nasopharyngeal carcinoma (NPC), but the radioresistance remains a major
obstacle. Osthole, a natural coumarin derivative, has been shown to have
anti-tumor and anti-inflammatory activity. However, the relationship between
osthole and NPC treatment, especially for radiotherapy, is still elusive.
Methods: Osthole with or without X ray radiotherapy treated with CNE2
cells, a human EC cell line. Cell viability, proliferation, migration and
apoptosis were measured by MTT, colony formation, Annexin V/PI double staining,
Transwell assay, respectively. NPC tumor models were established on BALB/c nude
mice by subcutaneously injection of CNE2 cells and the effect of osthole and
radiotherapy on tumor growth in vivo was studied.
Results: We found that in a dose-dependent manner, osthole could
individually, and synergistically with radiotherapy, reduce NPC cell (CNE2)
viability, proliferation, migration, and invasion, and induce apoptosis,
respectively. This effect of anti-tumor growth and induction of apoptosis was
further confirmed in mice induced by subcutaneously injection with CNE2 cells
and following treated with osthole or/and radiation.
Conclusion: Osthole increases the effect of radiotherapy on anti-human
nasopharyngeal cancer.
Keywords: osthole, radiotherapy, human nasopharyngeal carcinoma,
tumorigenesis, proliferation, apoptosis
